[go: up one dir, main page]

DE3162691D1 - 4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines - Google Patents

4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines

Info

Publication number
DE3162691D1
DE3162691D1 DE8181401752T DE3162691T DE3162691D1 DE 3162691 D1 DE3162691 D1 DE 3162691D1 DE 8181401752 T DE8181401752 T DE 8181401752T DE 3162691 T DE3162691 T DE 3162691T DE 3162691 D1 DE3162691 D1 DE 3162691D1
Authority
DE
Germany
Prior art keywords
cyclohepta
benzo
medicines
preparation
furan derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181401752T
Other languages
English (en)
Inventor
Bernard Delbarre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAVOUNGOU GOMES LOUIS
Original Assignee
MAVOUNGOU GOMES LOUIS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAVOUNGOU GOMES LOUIS filed Critical MAVOUNGOU GOMES LOUIS
Application granted granted Critical
Publication of DE3162691D1 publication Critical patent/DE3162691D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)
DE8181401752T 1980-11-10 1981-10-30 4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines Expired DE3162691D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8023973A FR2493846A1 (fr) 1980-11-10 1980-11-10 Derives du 4h-benzo(4,5)cyclohepta(1,2-b)furanne, leur procede de preparation et leur application en tant que medicaments

Publications (1)

Publication Number Publication Date
DE3162691D1 true DE3162691D1 (en) 1984-04-19

Family

ID=9247856

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181401752T Expired DE3162691D1 (en) 1980-11-10 1981-10-30 4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines

Country Status (8)

Country Link
US (1) US4383995A (de)
EP (1) EP0057337B1 (de)
JP (1) JPS57108087A (de)
AT (1) ATE6648T1 (de)
AU (1) AU541236B2 (de)
CA (1) CA1192550A (de)
DE (1) DE3162691D1 (de)
FR (1) FR2493846A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203672B (it) * 1982-05-12 1989-02-15 Harvard College Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use
US5987181A (en) 1995-10-12 1999-11-16 Sharp Kabushiki Kaisha Coding and decoding apparatus which transmits and receives tool information for constructing decoding scheme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2344284A1 (fr) * 1976-03-17 1977-10-14 Cerm Cent Europ Rech Mauvernay Nouveaux composes tricycliques a cycle furannique et leur application comme antidepresseurs

Also Published As

Publication number Publication date
JPS57108087A (en) 1982-07-05
US4383995A (en) 1983-05-17
AU7711381A (en) 1982-05-20
CA1192550A (fr) 1985-08-27
FR2493846B1 (de) 1983-01-21
FR2493846A1 (fr) 1982-05-14
EP0057337B1 (de) 1984-03-14
ATE6648T1 (de) 1984-03-15
EP0057337A1 (de) 1982-08-11
AU541236B2 (en) 1984-12-20

Similar Documents

Publication Publication Date Title
PT73601B (en) Process for the preparation of piperidilydene derivatives having pharmaceutical properties
DE3060160D1 (en) Arylethers, process for their preparation and medicines containing them
EG20726A (en) Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
DE3162691D1 (en) 4h-benzo(4,5)cyclohepta(1,2-b)furan derivatives, process for their preparation and their use as medicines
ES515744A0 (es) "procedimiento de preparacion de derivados de amino-2-tetrahidro-1,2,3,4-naftaleno".
IL67547A (en) Process for the preparation of 2-acyl-1,3,4,6,7,11b-hexahydro-2h-pyrazino-(2,1-a)-isoquinolin-4-ones and the novel 4-acyl-1-phenethylpiperazine-2-one derivatives as intermediates therefor
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
ES8304571A1 (es) "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas".
ES8401088A1 (es) Un procedimiento para la produccion de derivados de fosforamida.
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
DE3463770D1 (en) Thieno(2,3-6)pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
CH610887A5 (en) Process for the preparation of new 7-benzoyl-2-indolinones
IL61662A (en) 7-cyano-2,3,4,5-tetrahydro-1h-dibenz(2,3:6,7)oxepino(4,5-d)-azepines,their preparation and pharmaceutical compositions containing them
ES478143A1 (es) Un procedimiento para la fabricacion de compuestos heteroci-clicos nitrogenados.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee